Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?

Francesco Panza; Madia Lozupone; Mark Watling; Bruno Pietro Imbimbo

doi:10.1080/14737175.2019.1621751

Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?

Francesco Panza, Madia Lozupone, Mark Watling, Bruno Pietro Imbimbo

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	599-602
Number of pages	4
Journal	Expert Review of Neurotherapeutics
Volume	19
Issue number	7
DOIs	https://doi.org/10.1080/14737175.2019.1621751
Publication status	Published - Jul 3 2019
Externally published	Yes

Keywords

Alzheimer’s disease
BACE inhibitors
cognitive disorders
dementia
lifestyle
MCI

ASJC Scopus subject areas

Neuroscience(all)
Clinical Neurology
Pharmacology (medical)

Access to Document

10.1080/14737175.2019.1621751

Cite this

Panza, F., Lozupone, M., Watling, M., & Imbimbo, B. P. (2019). Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease? Expert Review of Neurotherapeutics, 19(7), 599-602. https://doi.org/10.1080/14737175.2019.1621751

@article{e27c346d848843aca024cff6c9e2074b,

title = "Do BACE inhibitor failures in Alzheimer patients challenge the amyloid hypothesis of the disease?",

keywords = "Alzheimer{\textquoteright}s disease, BACE inhibitors, cognitive disorders, dementia, lifestyle, MCI",

author = "Francesco Panza and Madia Lozupone and Mark Watling and Imbimbo, {Bruno Pietro}",

year = "2019",

month = jul,

day = "3",

doi = "10.1080/14737175.2019.1621751",

language = "English",

volume = "19",

pages = "599--602",

journal = "Expert Review of Neurotherapeutics",

issn = "1473-7175",